Results of early phase anti- IL-17 reported from WMR

Dr. Martin, Head and Eggebeen and colleagues reported the results of an early phase clinical trial conducted at West Michigan Rheumatology as a part of their broader thread of investigations of innovative biologic therapy for rheumatoid arthritis.  

Click the link to access the article

© 2019 West Michigan Rheumatology, PLLC  1155 East Paris SE, Suite 100  Grand Rapids, MI 49546   Voice 616.459.8088    FAX 616.459.8312